PAREXEL is to create 130 new jobs at its new “global decision-making hub” in Kilmainham, Dublin, it was announced today.

The biopharmaceutical services firm, which already employs 70 people, is recruiting over the next 12 to 18 months across all areas of their business – clinical, technology, legal, consulting, and logistics – and at all levels, including senior roles.

“Europe is important to our growth and business strategy, and Ireland specifically is a key country from which we can better serve our customers and continue our growth,” said Douglas A Batt, senior vice president and general counsel of PAREXEL.

“This office will be a global decision-making hub for our Company. Senior leaders based here will be making strategic decisions for the company worldwide, and this office will play a critical role in continuing to bring PAREXEL’s global brand to the world.”

Making the announcement, Minister for Jobs Richard Bruton TD said: “Today’s announcement that PAREXEL is adding 130 jobs in Kilmainham is a great boost and an example of the wide range of different types of jobs that Ireland can attract in this sector.

“I look forward to working closely with Douglas and the team at PAREXEL as they roll out this project.”

Welcoming PAREXEL’s announcement, Martin Shanahan, CEO, IDA Ireland said: “PAREXEL’s decision to locate in Ireland is an endorsement of the skills available to biopharmaceutical companies here.

“Ireland is the perfect place in which to locate a Global Hub – our location facilitates access into Europe, the Middle East and further afield. IDA Ireland has targeted the Life Sciences, and in particular, the Biopharmaceuticals sector for several years now – PAREXEL will be joining a very large cluster of biopharma companies that have already chosen Ireland as a place to locate business.”